John Waas
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Cancer Treatment and Pharmacology
Papers in
-
- Protein Degradation and Inhibitors 2
- Angiogenesis and VEGF in Cancer 2
- Oncology 4
- Cancer Treatment and Pharmacology 3
- Co-authors
- Keith R. McCrae (3 shared papers)Scot C. Remick (2 shared papers)Kelly M. Robertson (2 shared papers)Afshin Dowlati (2 shared papers)William P. Petros (1 shared paper)John A. Jesberger (1 shared paper)Matthew M. Cooney (1 shared paper)Anne L. Taylor (1 shared paper)
- Journals
- Blood (2 papers)Clinical Cancer Research (1 paper)Journal of Vascular Surgery (1 paper)EClinicalMedicine (1 paper)PubMed (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
John Waas
6 papers receiving 473 citations
Peers
Comparison fields: 5 of 61
- Hematology 109
- Oncology 193
- Cancer Research 87
- Molecular Biology 261
- Endocrinology, Diabetes and Metabolism 59
Countries citing papers authored by John Waas
This map shows the geographic impact of John Waas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Waas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Waas more than expected).
Fields of papers citing papers by John Waas
This network shows the impact of papers produced by John Waas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Waas. The network helps show where John Waas may publish in the future.
Co-authors
The 25 scholars most cited alongside John Waas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer. | 2002 | 347 |
| 2 | 2012 | 88 | |
| 3 | 2005 | 30 | |
| 4 | 2002 | 16 | |
| 5 | 2023 | 3 | |
| 6 | 2011 | 3 |
About John Waas
John Waas is a scholar working on Molecular Biology, Oncology, Hematology, Cancer Research and Genetics, having authored 6 papers that have together received 487 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Protein Degradation and Inhibitors (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Multiple Myeloma Research and Treatments (2 papers), Hemophilia Treatment and Research (1 paper), Lung Cancer Diagnosis and Treatment (1 paper) and Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (109 citations), Oncology (193 citations), Cancer Research (87 citations), Molecular Biology (261 citations) and Endocrinology, Diabetes and Metabolism (59 citations). John Waas has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Keith R. McCrae, Scot C. Remick, Kelly M. Robertson, Afshin Dowlati, William P. Petros, John A. Jesberger, Matthew M. Cooney, Anne L. Taylor, Bruce S. Stambler and Jonathan S. Lewin. Their work appears in journals such as Blood, Clinical Cancer Research, Journal of Vascular Surgery, EClinicalMedicine and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.